Inflammatory triggers of lymphangiogenesis.
Identifieur interne : 003E13 ( PubMed/Corpus ); précédent : 003E12; suivant : 003E14Inflammatory triggers of lymphangiogenesis.
Auteurs : Carla Mouta ; Mélanie HeroultSource :
- Lymphatic research and biology [ 1539-6851 ] ; 2003.
English descriptors
- KwdEn :
- MESH :
- immunology : Lymphangiogenesis.
- pathology : Endothelium, Lymphatic, Extracellular Matrix, Inflammation, Lymphatic Vessels.
- Animals, Cell Movement, Disease Progression, Fibrosis, Humans, Lymphography, Neovascularization, Pathologic, Wound Healing.
Abstract
Inflammation is the common denominator to the postnatal events that overlap with lymphatic vessel growth, or lymphangiogenesis. Undoubtedly, inflammation and accompanying fluid overload are cardinal factors in wound healing, lymphedema, the pathogenesis of some forms of lymphangiomatosis, and solid tumor lymphangiogenesis. The assertion that inflammation actually triggers lymphangiogenesis lies in the evidence set forth below that inflammation is the usual precursor to tissue repair and regeneration. Moreover, the panel of pro-inflammatory and anti-inflammatory molecules that orchestrates the inflammatory response abounds with cytokines and chemokines that foster survival, migration, and proliferation of lymphatic endothelial cells. Finally, both interstitial fluid overload and increased demand for removal of leukocytes can benefit from lymphangiogenesis, although the mechanisms controlling the exit of leukocytes from tissues via the lymphatics are practically unknown. The pertinent question actually is how and why inflammation presents with formation of new lymph vessels in liver fibrosis but not in rheumatoid arthritis. One possible explanation is that organ-specific histological and functional properties of the lymphatic endothelium gauge their response to death, survival, and proliferative factors. Alternatively, the decision to remain quiescent, proliferate or regress resides within the stroma microenvironment.
PubMed: 15624438
Links to Exploration step
pubmed:15624438Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inflammatory triggers of lymphangiogenesis.</title>
<author><name sortKey="Mouta, Carla" sort="Mouta, Carla" uniqKey="Mouta C" first="Carla" last="Mouta">Carla Mouta</name>
<affiliation><nlm:affiliation>Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA. moutac@mmc.org</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Heroult, Melanie" sort="Heroult, Melanie" uniqKey="Heroult M" first="Mélanie" last="Heroult">Mélanie Heroult</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:15624438</idno>
<idno type="pmid">15624438</idno>
<idno type="wicri:Area/PubMed/Corpus">003E13</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E13</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Inflammatory triggers of lymphangiogenesis.</title>
<author><name sortKey="Mouta, Carla" sort="Mouta, Carla" uniqKey="Mouta C" first="Carla" last="Mouta">Carla Mouta</name>
<affiliation><nlm:affiliation>Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA. moutac@mmc.org</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Heroult, Melanie" sort="Heroult, Melanie" uniqKey="Heroult M" first="Mélanie" last="Heroult">Mélanie Heroult</name>
</author>
</analytic>
<series><title level="j">Lymphatic research and biology</title>
<idno type="ISSN">1539-6851</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Cell Movement</term>
<term>Disease Progression</term>
<term>Endothelium, Lymphatic (pathology)</term>
<term>Extracellular Matrix (pathology)</term>
<term>Fibrosis</term>
<term>Humans</term>
<term>Inflammation (pathology)</term>
<term>Lymphangiogenesis (immunology)</term>
<term>Lymphatic Vessels (pathology)</term>
<term>Lymphography</term>
<term>Neovascularization, Pathologic</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Lymphangiogenesis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endothelium, Lymphatic</term>
<term>Extracellular Matrix</term>
<term>Inflammation</term>
<term>Lymphatic Vessels</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Movement</term>
<term>Disease Progression</term>
<term>Fibrosis</term>
<term>Humans</term>
<term>Lymphography</term>
<term>Neovascularization, Pathologic</term>
<term>Wound Healing</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Inflammation is the common denominator to the postnatal events that overlap with lymphatic vessel growth, or lymphangiogenesis. Undoubtedly, inflammation and accompanying fluid overload are cardinal factors in wound healing, lymphedema, the pathogenesis of some forms of lymphangiomatosis, and solid tumor lymphangiogenesis. The assertion that inflammation actually triggers lymphangiogenesis lies in the evidence set forth below that inflammation is the usual precursor to tissue repair and regeneration. Moreover, the panel of pro-inflammatory and anti-inflammatory molecules that orchestrates the inflammatory response abounds with cytokines and chemokines that foster survival, migration, and proliferation of lymphatic endothelial cells. Finally, both interstitial fluid overload and increased demand for removal of leukocytes can benefit from lymphangiogenesis, although the mechanisms controlling the exit of leukocytes from tissues via the lymphatics are practically unknown. The pertinent question actually is how and why inflammation presents with formation of new lymph vessels in liver fibrosis but not in rheumatoid arthritis. One possible explanation is that organ-specific histological and functional properties of the lymphatic endothelium gauge their response to death, survival, and proliferative factors. Alternatively, the decision to remain quiescent, proliferate or regress resides within the stroma microenvironment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15624438</PMID>
<DateCreated><Year>2004</Year>
<Month>12</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>02</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2007</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1539-6851</ISSN>
<JournalIssue CitedMedium="Print"><Volume>1</Volume>
<Issue>3</Issue>
<PubDate><Year>2003</Year>
</PubDate>
</JournalIssue>
<Title>Lymphatic research and biology</Title>
<ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Inflammatory triggers of lymphangiogenesis.</ArticleTitle>
<Pagination><MedlinePgn>201-18</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Inflammation is the common denominator to the postnatal events that overlap with lymphatic vessel growth, or lymphangiogenesis. Undoubtedly, inflammation and accompanying fluid overload are cardinal factors in wound healing, lymphedema, the pathogenesis of some forms of lymphangiomatosis, and solid tumor lymphangiogenesis. The assertion that inflammation actually triggers lymphangiogenesis lies in the evidence set forth below that inflammation is the usual precursor to tissue repair and regeneration. Moreover, the panel of pro-inflammatory and anti-inflammatory molecules that orchestrates the inflammatory response abounds with cytokines and chemokines that foster survival, migration, and proliferation of lymphatic endothelial cells. Finally, both interstitial fluid overload and increased demand for removal of leukocytes can benefit from lymphangiogenesis, although the mechanisms controlling the exit of leukocytes from tissues via the lymphatics are practically unknown. The pertinent question actually is how and why inflammation presents with formation of new lymph vessels in liver fibrosis but not in rheumatoid arthritis. One possible explanation is that organ-specific histological and functional properties of the lymphatic endothelium gauge their response to death, survival, and proliferative factors. Alternatively, the decision to remain quiescent, proliferate or regress resides within the stroma microenvironment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mouta</LastName>
<ForeName>Carla</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA. moutac@mmc.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Heroult</LastName>
<ForeName>Mélanie</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>1P20RR15555-01</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Lymphat Res Biol</MedlineTA>
<NlmUniqueID>101163587</NlmUniqueID>
<ISSNLinking>1539-6851</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004729" MajorTopicYN="N">Endothelium, Lymphatic</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005109" MajorTopicYN="N">Extracellular Matrix</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042583" MajorTopicYN="N">Lymphangiogenesis</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008220" MajorTopicYN="N">Lymphography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>148</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>12</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>12</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15624438</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003E13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:15624438 |texte= Inflammatory triggers of lymphangiogenesis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15624438" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |